Clinical Study

A Phase Ib Multi-Cohort Trial Of Mk-3475 (Pembrolizumab) In Subjects With Hematologic Malignancies

Posted Date: Mar 16, 2016

  • Investigator: Trisha Wise-Draper
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

This is a research study to test an investigational drug, pembrolizumab, which has been approved for use in certain types of adult melanoma and lung cancer however it has not been approved in any other cancers.


To Be Eligible To Participate Patients Must Have Cancer Of The Blood, Bone Marrow, Or Lymph Nodes.


Mk3475-013, Hematology, Cancer, Phase I, Keynote

For More Information:

Uc Cancer Institute

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.